Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mirkin

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Journal of Cellular Physiology|January 30, 2013
Evolution of the tissue selective estrogen complex (TSEC)Barry S Komm, Sebastian Mirkin
Menopause (New York, N.Y.)|October 27, 2018
A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopauseColton Biehl, Olivia Plotsker, Sebastian Mirkin
Women'S Health (London, England)|March 8, 2014
Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopauseSebastian Mirkin, Barry Komm, James H Pickar
Climacteric : the Journal of the International Menopause Society|March 10, 2004
Hormone therapy and endometrial angiogenesisSebastian Mirkin, Francisco Navarro, David F Archer
Expert Opinion on Drug Delivery|September 3, 2020
Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinionJames H Liu, Brian Bernick, Sebastian Mirkin
Expert Review of Clinical Pharmacology|July 9, 2019
A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopauseDavid F Archer, Brian A Bernick, Sebastian Mirkin
Fertility and Sterility|May 9, 2008
Return to fertility after cessation of a continuous oral contraceptiveKurt Barnhart, Sebastian Mirkin, Gary Grubb, et al.
Steroids|June 15, 2014
Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone lossBarry S Komm, Sebastian Mirkin, Simon N Jenkins
Expert Opinion on Drug Safety|August 8, 2013
Conjugated estrogens for the treatment of menopausal symptoms: a review of safety dataSebastian Mirkin, Barry S Komm, James H Pickar
Maturitas|August 16, 2014
Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapyStuart L Silverman, Barry S Komm, Sebastian Mirkin
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Journal of Cellular Physiology|January 30, 2013
Evolution of the tissue selective estrogen complex (TSEC)Barry S Komm, Sebastian Mirkin
Menopause (New York, N.Y.)|October 27, 2018
A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopauseColton Biehl, Olivia Plotsker, Sebastian Mirkin
Women'S Health (London, England)|March 8, 2014
Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopauseSebastian Mirkin, Barry Komm, James H Pickar
Climacteric : the Journal of the International Menopause Society|March 10, 2004
Hormone therapy and endometrial angiogenesisSebastian Mirkin, Francisco Navarro, David F Archer
Expert Opinion on Drug Delivery|September 3, 2020
Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinionJames H Liu, Brian Bernick, Sebastian Mirkin
Expert Review of Clinical Pharmacology|July 9, 2019
A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopauseDavid F Archer, Brian A Bernick, Sebastian Mirkin
Fertility and Sterility|May 9, 2008
Return to fertility after cessation of a continuous oral contraceptiveKurt Barnhart, Sebastian Mirkin, Gary Grubb, et al.
Steroids|June 15, 2014
Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone lossBarry S Komm, Sebastian Mirkin, Simon N Jenkins
Expert Opinion on Drug Safety|August 8, 2013
Conjugated estrogens for the treatment of menopausal symptoms: a review of safety dataSebastian Mirkin, Barry S Komm, James H Pickar
Maturitas|August 16, 2014
Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapyStuart L Silverman, Barry S Komm, Sebastian Mirkin
Pageof 11